ストックスクリーナーアプリを入手
25.04
0.16%
0.04
アフターアワーズ：
24.54
-0.50
-2.00%
前日終値:
$25.00
開ける：
$25
24時間の取引高:
77,895
Relative Volume:
0.75
時価総額：
$362.71M
収益：
$1.80M
当期純損益:
$1.76B
株価収益率:
0.211
EPS:
118.674
ネットキャッシュフロー:
$-149.23M
1週間 パフォーマンス:
+4.90%
1か月 パフォーマンス:
+8.49%
6か月 パフォーマンス:
+102.75%
1年 パフォーマンス:
+87.71%
1日の値動き範囲:
$24.28
$25.25
1週間の範囲:
$22.40
$25.61
52週間の値動き範囲:
$10.80
$25.61
Inhibrx Biosciences Inc Stock (INBX) Company Profile
名前
Inhibrx Biosciences Inc
セクター
電話
(858) 795-4220
住所
11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA
INBX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
INBX
Inhibrx Biosciences Inc
|
25.04 | 345.77M | 1.80M | 1.76B | -149.23M | 118.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
388.94 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.38 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
443.64 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
677.32 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
308.63 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Inhibrx Biosciences Inc Stock (INBX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-07-23 | 開始されました | JMP Securities | Mkt Perform |
| 2024-01-23 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-03-16 | 開始されました | SMBC Nikko | Outperform |
| 2021-09-21 | 開始されました | JMP Securities | Mkt Outperform |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2020-09-14 | 開始されました | Credit Suisse | Outperform |
| 2020-09-14 | 開始されました | Evercore ISI | Outperform |
すべてを表示
Inhibrx Biosciences Inc (INBX) 最新ニュース
How to monitor Inhibrx Biosciences Inc. with trend dashboardsAnalyst Downgrade & Long-Term Safe Investment Plans - Newser
Momentum Traders Eye Inhibrx Biosciences Inc. for Quick BounceJuly 2025 PreEarnings & Growth Focused Stock Reports - classian.co.kr
Inhibrx Biosciences Inc. Recovery Likely Here’s What Data ShowsWeekly Stock Analysis & Long-Term Investment Growth Plans - classian.co.kr
Quant Models Detect Momentum Reversal in Inhibrx Biosciences Inc.2025 Growth vs Value & Low Drawdown Investment Strategies - newsyoung.net
Inhibrx Biosciences Inc. stock outlook for YEARMarket Sentiment Report & Weekly Sector Rotation Insights - Newser
Backtesting results for Inhibrx Biosciences Inc. trading strategiesJuly 2025 Catalysts & Fast Gaining Stock Strategy Reports - Newser
How to forecast Inhibrx Biosciences Inc. trends using time seriesQuarterly Trade Review & High Win Rate Trade Tips - Newser
Analyzing drawdowns of Inhibrx Biosciences Inc. with statistical tools2025 Dividend Review & Verified Entry Point Signals - Newser
Is it too late to sell Inhibrx Biosciences Inc.2025 Breakouts & Breakdowns & Technical Confirmation Alerts - Newser
Key resistance and support levels for Inhibrx Biosciences Inc.July 2025 Market Mood & Proven Capital Preservation Methods - Newser
Predicting Inhibrx Biosciences Inc. trend using moving averagesJuly 2025 Closing Moves & Consistent Income Trade Ideas - Newser
Published on: 2025-08-20 02:19:27 - Newser
How to build a dashboard for Inhibrx Biosciences Inc. stockQuarterly Performance Summary & Accurate Technical Buy Alerts - Newser
Is Inhibrx Biosciences Inc. trending in predictive chart modelsEarnings Overview Summary & Weekly Breakout Stock Alerts - Newser
Top chart patterns to watch in Inhibrx Biosciences Inc.Weekly Stock Report & Momentum Based Trading Ideas - Newser
How to integrate Inhibrx Biosciences Inc. into portfolio analysis tools2025 Stock Rankings & Weekly Watchlist of Top Performers - Newser
News impact scoring models applied to Inhibrx Biosciences Inc.Portfolio Update Report & Stepwise Trade Signal Guides - Newser
Inhibrx Biosciences Inc. stock prediction for this week2025 Buyback Activity & Safe Capital Growth Stock Tips - Newser
Using flow based indicators on Inhibrx Biosciences Inc.July 2025 WrapUp & Community Trade Idea Sharing Platform - Newser
Published on: 2025-08-19 05:33:15 - Newser
Short Covering May Lift Inhibrx Biosciences Inc. in Near Term2025 Technical Patterns & Entry Point Strategy Guides - kangso.co.kr
Inhibrx Biosciences Inc. Volume Confirms Breakout — Analysts Bullish2025 Year in Review & Weekly High Return Forecasts - Newser
Real time breakdown of Inhibrx Biosciences Inc. stock performanceWeekly Gains Summary & Technical Buy Zone Confirmations - Newser
Published on: 2025-08-18 02:46:49 - Newser
Sentiment analysis tools applied to Inhibrx Biosciences Inc.Trade Risk Report & AI Based Buy and Sell Signals - Newser
Reversal indicators forming on Inhibrx Biosciences Inc. stockJuly 2025 Fed Impact & Daily Market Momentum Tracking - Newser
What’s the recovery path for long term holders of Inhibrx Biosciences Inc.Earnings Overview Summary & AI Enhanced Trade Execution Alerts - Newser
Inhibrx Biosciences Inc. stock trendline breakdown2025 Retail Activity & Verified Entry Point Signals - Newser
Visual trend scoring systems applied to Inhibrx Biosciences Inc.Trade Exit Summary & Safe Capital Growth Tips - Newser
Inhibrx Biosciences (NASDAQ:INBX) Upgraded by Wall Street Zen to Hold Rating - Defense World
Inhibrx Biosciences Inc. stock trend outlook and recovery path2025 Macro Impact & Low Drawdown Momentum Ideas - Newser
Will Inhibrx Biosciences Inc. benefit from sector rotation2025 Price Targets & Fast Moving Stock Trade Plans - thegnnews.com
Inhibrx Biosciences Inc. stock momentum explainedJuly 2025 Patterns & Weekly Top Stock Performers List - Newser
Inhibrx Biosciences Inc (INBX) 財務データ
収益
当期純利益
現金流量
EPS
Inhibrx Biosciences Inc (INBX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Kayyem Jon Faiz | Director |
Nov 20 '24 |
Buy |
14.19 |
37,500 |
532,204 |
69,843 |
| Lappe Mark | Chief Executive Officer |
Sep 12 '24 |
Buy |
15.05 |
26,963 |
405,793 |
692,511 |
| Lappe Mark | Chief Executive Officer |
Sep 16 '24 |
Buy |
17.13 |
13,037 |
223,324 |
705,548 |
| Vuori Kristiina MD | Director |
Sep 11 '24 |
Buy |
15.07 |
6,457 |
97,307 |
13,776 |
| Vuori Kristiina MD | Director |
Sep 10 '24 |
Buy |
15.00 |
179 |
2,685 |
7,319 |
| Lappe Mark | Chief Executive Officer |
Sep 06 '24 |
Buy |
15.29 |
26,000 |
397,540 |
647,548 |
| Lappe Mark | Chief Executive Officer |
Sep 09 '24 |
Buy |
15.21 |
9,500 |
144,495 |
657,048 |
| Lappe Mark | Chief Executive Officer |
Sep 10 '24 |
Buy |
15.19 |
8,500 |
129,115 |
665,548 |
| Lappe Mark | Chief Executive Officer |
Sep 03 '24 |
Buy |
15.81 |
20,000 |
316,263 |
165,000 |
| Lappe Mark | Chief Executive Officer |
Aug 29 '24 |
Buy |
14.03 |
10,000 |
140,300 |
135,000 |
1.38%
0.27%
大文字化:
|
ボリューム (24 時間):